12,500 results match your criteria: "Adrenal Carcinoma"

Most members of the genus Orthonairovirus, represented by Crimean-Congo hemorrhagic fever virus and Nairobi sheep disease virus, are tick-borne, and some have become a public health concern in recent years. Here, we report the isolation and genetic and biological characterization of a new orthonairovirus, designated as "Iwanai Valley virus" (IWVV), from Ixodes ovatus ticks in Hokkaido, Japan. The amino acid sequence of the viral nucleoprotein (NP) was found to be 34-45% identical to those of known orthonairoviruses.

View Article and Find Full Text PDF

Background: Kinectin 1 () is a membrane protein involved in intracellular organelle motility. However, the role of in human pan-cancer lacks systematic analysis and evaluation. The aim of this study is to evaluate the expression profile and clinical value in human cancers by performing a pan-cancer analysis of .

View Article and Find Full Text PDF

Renal cell carcinoma is the most common type of primary renal cancer, and clear cell carcinoma is the most common subtype, accounting for approximately 70% of all adult renal cell carcinoma cases. At the time of diagnosis, many patients already have metastatic manifestations. Cutaneous metastasis of renal clear cell carcinoma is very rare and usually represents a poor prognosis, mostly affecting the head and neck.

View Article and Find Full Text PDF

Adrenocortical carcinomas (ACCs) are rare and aggressive malignancies of adrenal cortex, associated with largely unknown mechanisms of biological development and poor prognosis. Currently, mitotane is the sole approved drug for treating advanced adrenocortical carcinomas (ACCs) and is being utilized more frequently as postoperative adjuvant therapy. Although it is understood that mitotane targets the adrenal cortex and disrupts steroid production, its precise mechanism of action requires further exploration.

View Article and Find Full Text PDF

Background/objectives: Adrenocortical tumors (ACTs), including adrenocortical adenoma (ACA) and carcinoma (ACC), represent 0.3-0.4% of pediatric tumors.

View Article and Find Full Text PDF

Background: Immune checkpoint inhibitors (ICIs) are emerging as important drugs for patients with locally advanced esophageal cancer (EC). Yet, immune-related adverse events (irAEs) may be a major obstacle for these population. Multidisciplinary team (MDT) is an efficient way to deal with such conditions.

View Article and Find Full Text PDF

Background: Cancer represents a highly intricate disease, characterized by the uncontrolled proliferation and invasion of aberrant cells, leading to widespread global morbidity and mortality. This study investigates the influence of CD19, a marker specific to B-cells, within the tumor microenvironment (TME) across a spectrum of cancer types.

Methodology: To explore the role of CD19, we employed a wide array of bioinformatics tools and databases, including UALCAN, GEPIA2, univariate Cox regression, KM plotter, HPA, GSCA, cBioPortal, TISIDB, and DAVID.

View Article and Find Full Text PDF

MMP9 in pan-cancer and computational study to screen for MMP9 inhibitors.

Am J Transl Res

November 2024

Lower Extremity Division, Orthopedic Trauma Department, Honghui Hospital, Xi'an Jiaotong University Youyi East Road No. 555, Beilin District, Xi'an, Shaanxi, China.

Purpose: The stromal cell protein metalloproteinase 9 (MMP9), associated with extracellular matrix degradation and remodeling, promotes tumor invasion and metastasis and regulates cell adhesion molecule and cytokine activity. This study evaluated MMP9 in pan-cancer and screened for compounds and drug candidates that can inhibit it.

Methods: MMP9 expression in pan-cancer tissues was evaluated in a pan-cancer dataset from the University of California Santa Cruz database, along with the correlation between MMP9 and the tumor microenvironment (TME), RNA modification genes, and tumor mutation burden.

View Article and Find Full Text PDF

Adrenocortical carcinoma (ACC) is a rare cancer with poor prognosis, treated primarily through surgery and chemotherapy. Other treatments like radiation or thermal ablation for metastases have limited success, and recurrence is common. More effective management options are needed.

View Article and Find Full Text PDF

Letter to the editor on "Identifying genomic signatures of recurrence in adrenocortical carcinoma after R0 resection".

Surgery

December 2024

The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Suzhou, Jiangsu, China. Electronic address:

View Article and Find Full Text PDF

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex that is associated with a poor prognosis. Developing effective treatment options for ACC is challenging owing to the current lack of representative preclinical models. This study addressed this limitation by developing and characterizing 3-dimensional (3D) cell cultures incorporating the ACC cell lines, MUC-1, HAC15, and H295R in a type I collagen matrix.

View Article and Find Full Text PDF

As a member of the DExD/H-box RNA helicase family, DHX34 has demonstrated a significant correlation with the development of multiple disorders. Nevertheless, a comprehensive investigation between DHX34 and pan-cancer remains unexplored. We analyzed the value of DHX34 in pan-cancer based on some databases, such as The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and The Human Protein Atlas (HPA) by use the R language as well as some online analysis tools, including STRING, TISIDB, TISCH2.

View Article and Find Full Text PDF

Introduction: Management of adrenal disease requires a multidisciplinary approach often involving varied specialists. Surgical management has often overlapped between general surgeons, usually with an interest in surgical endocrinology, or urologists with minimally invasive surgical skills. The objectives of this study were to define perioperative outcomes of contemporary Canadian adrenal surgery, and determine whether those outcomes are impacted by surgical subspecialty.

View Article and Find Full Text PDF

Primary malignant lymphomas originating in the adrenal gland, particularly of T-cell origin, are extremely rare. Here we present the primary unilateral adrenal anaplastic large cell lymphoma case. A 64-year-old Japanese male initially presented with fatigue and appetite loss.

View Article and Find Full Text PDF

Primary tumour resection in metastasised adrenocortical carcinoma: a systematic review.

Endocr Relat Cancer

November 2024

T van Ginhoven, Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, Netherlands.

Up to 30% of adrenocortical carcinoma (ACC) patients have metastasised disease upon initial presentation and systemic treatments currently fail to sufficiently improve survival. Palliative primary tumour resection can be considered for symptomatic relief, but its potential survival benefit remains a topic of debate. This systematic review therefore aims to assess the effect of primary tumour resection on overall survival in patients with metastatic ACC.

View Article and Find Full Text PDF

Introduction: Lung cancer is the second most common cancer worldwide and the leading cause of cancer deaths; non-small cell lung cancer (NSCLC) constitutes about 85% of lung cancer cases, with ALK fusions representing 3-6% of them. The SQSTM1-ALK fusion is a rare finding in NSCLC, accounting for only 1.1% of ALK rearrangements.

View Article and Find Full Text PDF

Malignant thyroid neoplasm with ectopic Cushing's syndrome.

BMJ Case Rep

December 2024

Endocrinology, PGIMER, Chandigarh, India.

Article Synopsis
  • - A 30-something man was diagnosed with diabetes and hypertension after gaining 33 lbs, experiencing swelling, and showing signs of Cushing's syndrome like muscle weakness and easy bruising; he also had a growing neck mass. - Tests indicated high cortisol and ACTH levels without suppression, revealing a malignant thyroid mass and enlarged adrenal glands; fine-needle aspiration confirmed medullary thyroid carcinoma (MTC) with elevated calcitonin. - He was diagnosed with ectopic Cushing's syndrome from MTC, underwent surgeries to remove both adrenal glands and the thyroid, saw his ACTH levels normalize, but had residual tumor requiring radiation therapy.
View Article and Find Full Text PDF

Renal cell carcinoma (RCC) is the most common primary kidney neoplasm, with clear cell being the predominant histopathological type. Extra-renal RCC, a rare entity, occurs in locations outside the normal kidneys. This report presents a case of metastatic primary extra-renal RCC.

View Article and Find Full Text PDF

Whole genome profiling of primary and metastatic adrenocortical carcinoma unravels significant molecular events.

Pathol Res Pract

November 2024

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, 1300 York Ave, New York, NY 10065,  USA; Englander Institute for Precision Medicine, Weill Cornell Medicine, 413 East 69th Street, New York, NY 10021, USA. Electronic address:

Article Synopsis
  • * Key mutations were identified in various genes, such as APC and TP53, with significant genomic alterations including a unique RAD51 biallelic deleterious translocation linked to homologous recombination deficiency.
  • * The research also found no major differences in mutation load or genetic features between traditional and oncocytic ACC subtypes, revealing a broad range of genomic changes that may help guide future cancer treatment options.
View Article and Find Full Text PDF

Adrenal Cortical Carcinoma Presenting as CSCR.

Retin Cases Brief Rep

November 2024

Northern California Kaiser Permanente, Roseville, CA, USA.

Purpose: We describe a case of bilateral chronic central serous chorioretinopathy (CSCR) secondary to adrenal cortical carcinoma.

Methods: Case report of a 70-year-old Hispanic man presenting with bilateral multifocal CSCR.

Results: Clinical findings of bilateral chronic CSCR along with 160 µm of subretinal fluid (SRF) and choroidal thickness greater than 400 µm without enhanced depth optical coherence tomography was noted in a patient presenting with distortion in vision in both eyes and weight gain of 15 pounds, weakness, and fatigue starting 8 months prior.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers analyzed various datasets using advanced techniques to identify potential biomarkers, leading to the discovery of 77 progression-associated genes, with KPNA2 identified as a significant risk factor linked to poor outcomes.
  • * KPNA2 was found to be overexpressed in aggressive ACC cases, promoting cancer cell growth and suppressing immune response, indicating its potential as a key biomarker for predicting patient prognosis and treatment effectiveness.
View Article and Find Full Text PDF